These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12069012)

  • 1. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease.
    Kronborg G; Ostergaard C; Weis N; Nielsen H; Obel N; Pedersen SS; Price PA; Johansen JS
    Scand J Infect Dis; 2002; 34(5):323-6. PubMed ID: 12069012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer.
    Yamac D; Ozturk B; Coskun U; Tekin E; Sancak B; Yildiz R; Atalay C
    Adv Ther; 2008 Aug; 25(8):801-9. PubMed ID: 18670741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
    Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
    Cancer; 2002 Jul; 95(2):267-74. PubMed ID: 12124825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival.
    Johansen JS; Christensen IJ; Riisbro R; Greenall M; Han C; Price PA; Smith K; Brünner N; Harris AL
    Breast Cancer Res Treat; 2003 Jul; 80(1):15-21. PubMed ID: 12889595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease.
    Vind I; Johansen JS; Price PA; Munkholm P
    Scand J Gastroenterol; 2003 Jun; 38(6):599-605. PubMed ID: 12825867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of YKL-40 increases in patients with acute myocardial infarction.
    Nøjgaard C; Høst NB; Christensen IJ; Poulsen SH; Egstrup K; Price PA; Johansen JS
    Coron Artery Dis; 2008 Jun; 19(4):257-63. PubMed ID: 18480670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
    Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
    Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia.
    Bergmann OJ; Johansen JS; Klausen TW; Mylin AK; Kristensen JS; Kjeldsen E; Johnsen HE
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8644-52. PubMed ID: 16361549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction.
    Johansen JS; Kirwan JR; Price PA; Sharif M
    Scand J Rheumatol; 2001; 30(5):297-304. PubMed ID: 11727845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
    Roslind A; Johansen JS; Christensen IJ; Kiss K; Balslev E; Nielsen DL; Bentzen J; Price PA; Andersen E
    Int J Cancer; 2008 Feb; 122(4):857-63. PubMed ID: 17957792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YKL-40 in giant cells and macrophages from patients with giant cell arteritis.
    Johansen JS; Baslund B; Garbarsch C; Hansen M; Stoltenberg M; Lorenzen I; Price PA
    Arthritis Rheum; 1999 Dec; 42(12):2624-30. PubMed ID: 10616010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laborarory parameters.
    Matsumoto T; Tsurumoto T
    Clin Exp Rheumatol; 2001; 19(6):655-60. PubMed ID: 11791636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.
    Nordenbaek C; Johansen JS; Halberg P; Wiik A; Garbarsch C; Ullman S; Price PA; Jacobsen S
    Scand J Rheumatol; 2005; 34(4):293-7. PubMed ID: 16195162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease.
    Erzin Y; Uzun H; Karatas A; Celik AF
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e357-62. PubMed ID: 17725598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality.
    Wittenhagen P; Kronborg G; Weis N; Nielsen H; Obel N; Pedersen SS; Eugen-Olsen J
    Clin Microbiol Infect; 2004 May; 10(5):409-15. PubMed ID: 15113317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure.
    Bilim O; Takeishi Y; Kitahara T; Ishino M; Sasaki T; Suzuki S; Shishido T; Kubota I
    J Card Fail; 2010 Nov; 16(11):873-9. PubMed ID: 21055651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum YKL-40 is increased in patients with hepatic fibrosis.
    Johansen JS; Christoffersen P; Møller S; Price PA; Henriksen JH; Garbarsch C; Bendtsen F
    J Hepatol; 2000 Jun; 32(6):911-20. PubMed ID: 10898311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating YKL-40 levels during human endotoxaemia.
    Johansen JS; Krabbe KS; Møller K; Pedersen BK
    Clin Exp Immunol; 2005 May; 140(2):343-8. PubMed ID: 15807860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.
    Hormigo A; Gu B; Karimi S; Riedel E; Panageas KS; Edgar MA; Tanwar MK; Rao JS; Fleisher M; DeAngelis LM; Holland EC
    Clin Cancer Res; 2006 Oct; 12(19):5698-704. PubMed ID: 17020973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.
    Thöm I; Andritzky B; Schuch G; Burkholder I; Edler L; Johansen JS; Bokemeyer C; Schumacher U; Laack E
    Cancer; 2010 Sep; 116(17):4114-21. PubMed ID: 20564116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.